|
Other Treatment
Citations 191-200 of 726 total displayed.
|
Past content
(since Jan 1999):
|
- Editorials
Survival After Mitral Valve Replacement: Does the Valve Type and/or Size Make a Difference?
- R. Morton Bolman, III
Circulation 2007;115:1336-1338, doi:10.1161/CIRCULATIONAHA.106.686717
[Full text]
- Articles
Elastin Stabilization for Treatment of Abdominal Aortic Aneurysms
- Jason C. Isenburg, Dan T. Simionescu, Barry C. Starcher, and Narendra R. Vyavahare
Circulation published March 19, 2007, doi:10.1161/CIRCULATIONAHA.106.672873
[Abstract]
- Articles
The Impact of Valve Surgery on 6-Month Mortality in Left-Sided Infective Endocarditis
- Imad M. Tleyjeh, Hassan M.K. Ghomrawi, James M. Steckelberg, Tanya L. Hoskin, Zaur Mirzoyev, Nandan S. Anavekar, Felicity Enders, Sherif Moustafa, Farouk Mookadam, W. Charles Huskins, Walter R. Wilson, and Larry M. Baddour
Circulation published March 19, 2007, doi:10.1161/CIRCULATIONAHA.106.658831
[Abstract]
- Articles
A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance
- M. A. Tanner, R. Galanello, C. Dessi, G. C. Smith, M. A. Westwood, A. Agus, M. Roughton, R. Assomull, S. V. Nair, J. M. Walker, and D. J. Pennell
Circulation published March 19, 2007, doi:10.1161/CIRCULATIONAHA.106.648790
[Abstract]
- Articles
Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine. Consistency Across Subgroups in the African-American Heart Failure Trial
- Anne L. Taylor, Susan Ziesche, Clyde W. Yancy, Peter Carson, Keith Ferdinand, Malcolm Taylor, Kirkwood Adams, Adeoye Y. Olukotun, Elizabeth Ofili, S. William Tam, Michael L. Sabolinski, Manuel Worcel, Jay N. Cohn on behalf of the African-American Heart Failure Trial Investigators
Circulation published March 19, 2007, doi:10.1161/CIRCULATIONAHA.106.644013
[Abstract]
- Vascular Medicine
Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor- Activation
- Georg Hansmann, Roger A. Wagner, Stefan Schellong, Vinicio A. de Jesus Perez, Takashi Urashima, Lingli Wang, Ahmad Y. Sheikh, Renée S. Suen, Duncan J. Stewart, and Marlene Rabinovitch
Circulation 2007;115:1275-1284; published online before print as doi:10.1161/CIRCULATIONAHA.106.663120
[Abstract]
[Full text]
- Editorials
Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS-II): Prologue to COURAGE
- Spencer B. King, III
Circulation 2007;115:1064-1066, doi:10.1161/CIRCULATIONAHA.106.675454
[Full text]
- Articles
Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator-Activated Receptor- Activation
- Georg Hansmann, Roger A. Wagner, Stefan Schellong, Vinicio A. de Jesus Perez, Takashi Urashima, Lingli Wang, Ahmad Y. Sheikh, Renée S. Suen, Duncan J. Stewart, and Marlene Rabinovitch
Circulation published March 5, 2007, doi:10.1161/CIRCULATIONAHA.106.663120
[Abstract]
- Images in Cardiovascular Medicine
Tricyclic Cardiotoxicity Treated With Sodium Bicarbonate
- Candice Y.Y. Chan and W. Stephen Waring
Circulation 2007;115:e63-64e, doi:10.1161/CIRCULATIONAHA.106.657247
[Full text]
- Health Services and Outcomes Research
Quantifying Improvement in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization
- David M. Safley, John A. House, Steven B. Laster, William C. Daniel, John A. Spertus, and Steven P. Marso
Circulation 2007;115:569-575; published online before print as doi:10.1161/CIRCULATIONAHA.106.643346
[Abstract]
[Full text]
|
|
